# Scott M. Schuetze

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/scott-m-schuetze/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,625 |
| Field | Sarcoma Diagnosis and Treatment |
| h-index | 60 |
| i10-index | 133 |
| Last Known Institution | University of Michigan |
| OpenAlex ID | https://openalex.org/A5020992966 |
| ORCID iD | 0000-0002-7167-4163 |
| Works | 277 |

## Researcher papers

Showing 12 of 16.

- [Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial](https://scholariq.org/papers/pembrolizumab-in-advanced-soft-tissue-sarcoma-and-bone-sarcoma-sarc028-a/)
- [NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors](https://scholariq.org/papers/nccn-task-force-report-update-on-the-management-of-patients-with/)
- [Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/soft-tissue-sarcoma-version-2-2022-nccn-clinical-practice-guidelines-in-oncology/)
- [Integrative clinical genomics of metastatic cancer](https://scholariq.org/papers/integrative-clinical-genomics-of-metastatic-cancer/)
- [Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial](https://scholariq.org/papers/efficacy-and-safety-of-trabectedin-or-dacarbazine-for-metastatic-liposarcoma-or/)
- [Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing](https://scholariq.org/papers/identification-of-recurrent-nab2-stat6-gene-fusions-in-solitary-fibrous-tumor-by/)
- [Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002](https://scholariq.org/papers/randomized-phase-ii-study-of-gemcitabine-and-docetaxel-compared-with-gemcitabine/)
- [Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/soft-tissue-sarcoma-version-2-2018-nccn-clinical-practice-guidelines-in-oncology/)
- [Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study](https://scholariq.org/papers/safety-and-efficacy-of-denosumab-for-adults-and-skeletally-mature-adolescents/)
- [Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas](https://scholariq.org/papers/phase-ii-study-of-sorafenib-in-patients-with-metastatic-or-recurrent-sarcomas/)
- [Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules](https://scholariq.org/papers/efficacy-and-safety-of-trabectedin-in-patients-with-advanced-or-metastatic/)
- [Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between](https://scholariq.org/papers/return-of-genomic-results-to-research-participants-the-floor-the-ceiling-and-the/)

## Researcher topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Vascular Tumors and Angiosarcomas](https://scholariq.org/topics/vascular-tumors-and-angiosarcomas/)
- [Cardiac tumors and thrombi](https://scholariq.org/topics/cardiac-tumors-and-thrombi/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Researcher university

- [University of Michigan](https://scholariq.org/institutions/university-of-michigan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.